Youcare Pharmaceutical Group Co., Ltd. (688658.SS)
CNY 16.34
(1.18%)
CNY 16.34
(1.18%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 418.36 Million CNY | -23.43% |
| 2022 | 521.07 Million CNY | -26.34% |
| 2021 | 775.43 Million CNY | 24.24% |
| 2020 | 657.94 Million CNY | 50.24% |
| 2019 | 499.92 Million CNY | 2.1% |
| 2018 | 485.73 Million CNY | 32.28% |
| 2017 | 422.72 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 115.49 Million CNY | -2.0% |
| 2024 Q2 | 112.37 Million CNY | -14.1% |
| 2024 Q1 | 74.89 Million CNY | 24.5% |
| 2023 FY | - CNY | -23.43% |
| 2023 Q4 | 98.68 Million CNY | 294.01% |
| 2023 Q1 | 105.87 Million CNY | 237.6% |
| 2023 Q2 | 138.18 Million CNY | 30.52% |
| 2023 Q3 | -50.86 Million CNY | -136.81% |
| 2022 Q3 | 248.37 Million CNY | 140.27% |
| 2022 Q4 | 31.36 Million CNY | -87.37% |
| 2022 Q2 | 103.37 Million CNY | 54.96% |
| 2022 Q1 | 66.71 Million CNY | -72.26% |
| 2022 FY | - CNY | -26.34% |
| 2021 Q4 | 240.5 Million CNY | 25.24% |
| 2021 Q3 | 192.03 Million CNY | 7.69% |
| 2021 Q2 | 178.31 Million CNY | 110.84% |
| 2021 Q1 | 84.57 Million CNY | -67.63% |
| 2021 FY | - CNY | 24.24% |
| 2020 FY | - CNY | 50.24% |
| 2020 Q1 | 48.9 Million CNY | -67.45% |
| 2020 Q4 | 261.24 Million CNY | 8.58% |
| 2020 Q3 | 240.6 Million CNY | 104.71% |
| 2020 Q2 | 117.53 Million CNY | 140.35% |
| 2019 FY | - CNY | 2.1% |
| 2019 Q4 | 150.25 Million CNY | 107.93% |
| 2019 Q3 | -1.89 Billion CNY | 0.0% |
| 2018 FY | - CNY | 32.28% |
| 2017 FY | - CNY | 0.0% |